Informational only โ€” not medical advice. Read our disclaimer.
How the system works

What Is a Pharmacy Benefit Manager (PBM)? Explained Simply

Reviewed by D.P., PharmD.

Key takeaways
  • A PBM is a middleman hired by your insurer or employer to run the prescription-drug side of your plan โ€” negotiating prices, building the formulary, and processing claims.
  • Three companies โ€” CVS Caremark, Express Scripts, and Optum Rx โ€” handle roughly 4 out of 5 U.S. prescription claims, according to the FTC.
  • PBMs make money through service fees, manufacturer rebates, and sometimes "spread pricing." Their behind-the-scenes deals decide which tier your drug lands on โ€” and your tier decides your copay.

You've never hired a pharmacy benefit manager. You've probably never heard of yours. But one of them has a hand in nearly every prescription you fill โ€” deciding which drugs your plan covers, what tier they sit on, and what the pharmacy gets paid. Here's how they work.

The 30-second definition

A pharmacy benefit manager is a company that acts as an intermediary between drug manufacturers and the organizations that pay for drug benefits โ€” health insurers, employer health plans, Medicare Part D plans, and state Medicaid programs. Your insurer or employer hires the PBM to manage the prescription-drug side of your coverage. The PBM doesn't manufacture drugs and doesn't see patients; it runs the machinery in between โ€” negotiating prices, deciding coverage, and processing the claim when you pick up a prescription.

The Big Three

Dozens of PBMs exist, but three giants dominate. According to the Federal Trade Commission, Optum Rx (owned by UnitedHealth Group), Express Scripts (owned by Cigna), and CVS Caremark (owned by CVS Health, which also owns the insurer Aetna) managed 79% of U.S. prescription drug claims on behalf of 270 million people in 2023.

Each is owned by a company that also owns a major health insurer, plus its own mail-order and specialty pharmacies. That vertical integration is why PBMs are so powerful โ€” and so controversial.

The four jobs a PBM does

In plain English, they do four things:

1. Negotiate prices and rebates with drug manufacturers

PBMs bargain with pharmaceutical companies for discounts and rebates โ€” payments manufacturers make to the PBM in exchange for favorable placement of their drug on the plan's formulary. A big rebate can land a drug on a lower tier; a drug with no rebate deal may sit on a higher tier or off the formulary entirely.

2. Build the formulary and set the tiers

The formulary is the plan's list of covered drugs, organized into tiers that determine your cost-sharing. The PBM designs it: which drugs are covered, which tier each sits on, and which need extra hurdles like prior authorization or step therapy. This is the job that most directly reaches your wallet โ€” the same drug can be a $10 Tier 1 copay or a $150 Tier 3 coinsurance depending on where the PBM placed it. (For the ways this can change out from under you, see why your copay went up.)

3. Process and adjudicate pharmacy claims

When the pharmacist scans your prescription, a claim goes to the PBM's computers, which check your coverage, deductible status, formulary tier, and contracted price โ€” approving or rejecting the fill in seconds. The PBM then reimburses the pharmacy. This invisible handshake is why your copay appears on the register before you've finished signing.

4. Build pharmacy networks and run mail-order and specialty pharmacies

PBMs decide which pharmacies are "preferred" (lower copays) or "standard" under your plan, and they operate their own mail-order and specialty pharmacies for maintenance and high-cost drugs. When your PBM owns pharmacies, it has a financial interest in where you fill.

How the money flows

PBMs earn revenue several ways โ€” and this is where the debate gets heated:

Service fees. Plans pay PBMs fees for the functions above โ€” negotiating, processing claims, running networks.

Rebates. PBMs negotiate rebates from manufacturers in exchange for preferred formulary placement, and they may retain a portion โ€” reportedly more common in the commercial employer market than in Medicare Part D. Here's the tension: rebates can help plans offer lower premiums, but to maximize rebate revenue, a PBM may favor a higher-priced drug with a big rebate over a cheaper drug with little or no rebate โ€” which can push list prices up and raise costs for people who pay based on list price (the uninsured, or anyone in a high-deductible phase).

Spread pricing. A PBM pays the dispensing pharmacy less for a drug than the amount it charges the insurer for that same drug, keeping the difference โ€” the "spread" โ€” as revenue. The practice has drawn particular scrutiny in Medicaid managed care, and several states have restricted or banned it.

PBMs sit in the middle of enormous money flows under largely private contracts, so outsiders โ€” including, often, the employers paying the bills โ€” can't fully see who keeps what. That opacity is a major driver of the reform debate.

Why all of this reaches your wallet

Here's the chain: a rebate deal between a manufacturer and the PBM influences formulary placement; the tier sets your cost-sharing; your cost-sharing is the copay on the register. When your copay jumps in January, a PBM may have renegotiated the formulary and moved your drug's tier โ€” or dropped it entirely.

PBMs also show up in the discount-card world: the cash prices behind coupons like GoodRx are negotiated between pharmacies and PBMs, which is why a coupon can sometimes beat your insurance price. (Our full comparison: GoodRx vs. insurance.)

The reform debate, in one neutral paragraph

PBMs have faced bipartisan scrutiny over business practices, market concentration, and lack of transparency. In early 2026, Congress enacted federal PBM provisions that will delink PBM compensation from drug prices and rebates in Medicare Part D, require PBMs to pass through 100% of rebates to employer health plans, and impose new transparency and reporting requirements. The FTC has also acted, including a 2026 settlement with Express Scripts over insulin rebate practices, and state-level legislative efforts have occurred in all 50 states. Where all of this lands for your copay is still playing out โ€” reasonable people disagree about whether PBMs are primarily cost-savers or cost-drivers. This site takes no side; the mechanics above are the part worth understanding regardless.

What you can actually do about it

You can't negotiate with a PBM directly โ€” but you can navigate the system it built:

  • Read your plan's formulary. It's a public document. Knowing your drugs' tiers before open enrollment tells you what next year will cost.
  • Ask about exceptions. If a formulary placement looks wrong for your situation, your doctor can request a tier exception or formulary exception โ€” the formal process for asking the plan to cover a drug differently. Medicare's appeals page explains how that process works; private plans have their own versions.
  • Talk to your doctor or pharmacist about your situation. They deal with formularies, tiers, and PBM-driven changes every day. Nothing in this article is a recommendation about any medication; those decisions belong to you and your clinicians.
Not medical advice.

This guide explains how pharmacy benefit managers work and how they affect drug pricing. It doesn't advise changing, stopping, or switching any medication โ€” those decisions belong to you, your doctor, and your pharmacist. Full disclaimer.

Sources